Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device
Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.
FDA highlights new Class I recall for Dexcom CGM app
Dexcom recalled its G6 smartphone app after a software error was causing it to stop working with no warning. This is a Class I recall, which means failing to follow the company's instructions could result in a serious adverse event.
Telehealth ketamine service sued after patient dies of overdose
Mindbloom, a telemedicine company that provides ketamine for depression and anxiety as part of a treatment program, is accused of negligence in the death of Philip Ward. But the facts leading up to his overdose are in dispute.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Cardiologist Peter Soukas becomes chief medical officer of carotid stent company
The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting.

TAVR shows ‘excellent safety’ at 30 days in low-risk patients

A new study published in the Journal of the American College of Cardiology provides reassurance that TAVR is a safe alternative to surgical aortic valve replacement (SAVR) in low-risk patients, as zero of the 200 people undergoing the transcatheter procedure died or experienced a disabling stroke within 30 days.

ASTRO 2018: SBRT an effective option for low-, intermediate-risk prostate cancer patients

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for patients with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Researchers highlight possible ‘neglected risk factor’ for MI

Certain antiphospholipid antibodies were detected more often after heart attacks than for age-matched controls, suggesting the markers could be used to identify patients at high risk of myocardial infarction, according to a study published Oct. 22 in the Annals of Internal Medicine.

ASTRO 2018: High-dose radiation therapy safe for kidney cancer patients with a single kidney

Using high-dose, high-precision radiation therapy to treat renal cell carcinoma (RCR) is safe for patients with one kidney, according to findings presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

Phone app boosts weight loss among low-income patients

A free phone app helped a low-income, obese patient population achieve clinically meaningful weight loss, researchers from Duke University reported in the American Journal of Preventive Medicine.

ASTRO 2018: African-Americans with prostate cancer respond better to radiation therapy than Caucasian men

Contrary to recent data suggesting African-Americans face a higher mortality risk from prostate cancer than Caucasian men, a new study presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting suggests African-American men may have higher cure rates when treated with radiation therapy than Caucasian men.

Study: There’s no such thing as ‘too fit’

Having reduced cardiorespiratory fitness (CRF) is as harmful to survival as coronary artery disease, smoking cigarettes or diabetes, suggests a retrospective study published Oct. 19 in JAMA Network Open.

Canada introduces tiered CVD screening for high school athletes

Canadian physicians are calling for nationwide CVD screening for all competitive high school athletes, CTV News reported this week of new guidelines issued at the Canadian Cardiovascular Congress in Toronto.

Clinical

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

FDA highlights new Class I recall for Dexcom CGM app

Telehealth ketamine service sued after patient dies of overdose

Pulmonary embolism thrombectomy use increases by more than 700%

Cardiologist Peter Soukas becomes chief medical officer of carotid stent company